Journal of Applied Physiology Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (August 17, 2006). doi:10.1152/japplphysiol.01576.2005
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
102/1/429    most recent
01576.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jayachandran, M.
Right arrow Articles by Miller, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jayachandran, M.
Right arrow Articles by Miller, V. M.
Submitted on December 15, 2005
Accepted on August 9, 2006

In Vivo Effects of Lipopolysaccharide and TLR4 on Platelet Production and Activity: Implications for Thrombotic Risk

Muthuvel Jayachandran1, Gregory J. Brunn2, Krzysztof Karnicki3, Randall S. Miller4, Whyte G. Owen5, and Virginia M. Miller1*

1 Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota, United States; Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, Minnesota, United States
2 Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota, United States; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, Minnesota, United States
3 Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States
4 Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, Minnesota, United States
5 Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, Minnesota, United States; Section of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, United States

* To whom correspondence should be addressed. E-mail: miller.virginia{at}mayo.edu.

Gram negative bacteria release lipopolysaccharides (LPS), which activate Toll-like-receptor-4 (TLR4) in the host initiating an inflammatory response to infection. Infection increases risk for thrombosis. Platelets contribute to defense from infection and to thrombosis. Experiments were designed to determine whether LPS, through TLR4 signaling, affects platelet phenotype. Platelet responses in wild type (WT) mice and mice that lack the TLR4 gene (dTLR4) were compared following a single non-lethal injection of LPS (0.2mg/kg/i.v.). Compared to WT mice, mice without TLR4 had fewer circulating platelets with lower RNA content and which were less responsive to thrombin activated expression of P-selectin but were equally sensitive to aggregation or ATP secretion. One week following the LPS injection, the time it takes for the circulating platelet pool to turnover, the number of circulating platelets, thrombin-induced expression of P-selectin and collagen-activated aggregation were increased comparably in both groups of mice. Therefore, the change of the platelet pool to an activated phenotype one week after a single exposure to LPS appears to arise from a process that is independent of TLR4. The persistence of the effect one week after the injection suggests that the changes reflect an action of LPS on megakaryocytes and their platelet progeny rather than on circulating platelets, which would have been cleared.




This article has been cited by other articles:


Home page
Circ. Res.Home page
P. Blair, S. Rex, O. Vitseva, L. Beaulieu, K. Tanriverdi, S. Chakrabarti, C. Hayashi, C. A. Genco, M. Iafrati, and J. E. Freedman
Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase
Circ. Res., February 13, 2009; 104(3): 346 - 354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jayachandran, R. D. Litwiller, W. G. Owen, J. A. Heit, T. Behrenbeck, S. L. Mulvagh, P. A. Araoz, M. J. Budoff, S. M. Harman, and V. M. Miller
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H931 - H938.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Cheli, D. Jensen, P. Marchese, D. Habart, T. Wiltshire, M. Cooke, J. A. Fernandez, J. Ware, Z. M. Ruggeri, and T. J. Kunicki
The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice
Blood, February 1, 2008; 111(3): 1266 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-T. Hong, J. Huang, T. D. Barrett, and B. R. Lucchesi
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H145 - H155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.